---

Market Overview

---

Endoscopes are medical devices that allow minimally invasive procedures by inserting them through natural body openings to observe internal organs or tissues in detail. These devices are commonly used for imaging and minor surgeries.

The Endoscopy Devices Market is projected to grow from USD 33,271 million in 2022 to USD 45,420 million by 2028, with a compound annual growth rate (CAGR) of 6.56% during the forecast period (2023-2028).

The COVID-19 pandemic had a significant impact on the endoscopy devices market initially, as elective procedures were canceled. However, the market gradually recovered as restrictions were lifted and endoscopic procedures resumed. Market players strategically launched innovative endoscopic devices and initiatives to regain growth momentum. For example, in April 2022, Fujifilm introduced the mobile training hub EndoRunner Tour to address endoscopy challenges in the post-COVID era. The emergence of new variants of COVID-19 strains was expected to have minimal impact on the endoscopy devices market, which was forecasted to remain stable.

The increasing prevalence of chronic and other diseases is expected to drive the adoption of endoscopy for diagnostic and therapeutic purposes, thereby contributing to market growth. A study published by the British Heart Foundation (BHF) in January 2022 highlighted the global burden of cardiovascular diseases, such as coronary heart disease, peripheral arterial disease, stroke, and atrial fibrillation. The demand for endoscopy procedures for diagnostic purposes is likely to rise due to the high burden of cardiovascular diseases, further fueling market growth.

Moreover, the growing importance and adoption of minimally invasive surgeries worldwide have led to a steady increase in the utilization of endoscopy devices for improved patient outcomes. Minimally invasive surgery (MIS) is preferred for many abdominal and pelvic surgeries due to its benefits, including reduced morbidity and faster recovery times. The increasing adoption of MIS will drive the use of endoscopy devices for surgical monitoring purposes, thereby boosting market growth.

Furthermore, manufacturers of endoscopy devices are increasingly focusing on technological advancements to develop advanced endoscopy systems, contributing to market growth. For example, FUJIFILM Healthcare launched a dual-channel endoscope approved by the United States Food and Drug Administration (FDA) for upper and lower gastrointestinal applications in November 2021. In June 2022, Getinge released an updated version of the ED-Flow automated endoscope reprocessor with enhanced digital connectivity and data management capabilities, offering improved uptime and increased productivity.

In summary, factors such as the high prevalence of chronic diseases, technological advancements, and product launches by market players are expected to drive significant growth in the global endoscopy devices market. However, challenges related to the lack of skilled technicians and infections caused by some endoscopes may hinder market growth.

---

Market Segmentation

---

The market is segmented based on various factors, including type of device, application, and region.

Segmentation by Type of Device
Endoscopes – Rigid Endoscope, Flexible Endoscope, Capsule Endoscope, and Robot-assisted Endoscope – Irrigation/Suction System, Access Device, Wound Protector, Insufflation Device, Operative Manual Instrument, and Other Endoscopic Operative Devices
Visualization Equipment – Endoscopic Camera, SD Visualization System, and HD Visualization System

Segmentation by Application
Gastroenterology
Pulmonology
Orthopedic Surgery
Cardiology
ENT Surgery
Gynecology
Neurology
Other Applications

Segmentation by Region
North America – United States, Canada, and Mexico
Europe – United Kingdom, Germany, France, Italy, Spain, and Rest of Europe
Asia-Pacific – China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific
Latin America – Brazil, Argentina, and Rest of Latin America
Middle East and Africa – South Africa, GCC, and Rest of Middle East and Africa

In terms of device types, the endoscopes segment held the largest market share in 2022, amounting to USD 13,056 million. It is projected to experience a compound annual growth rate (CAGR) of 6.71% over the forecast period. Within the endoscope scopes category, flexible endoscopes accounted for the majority of the segment, with USD 6,650 million in 2022 and an expected CAGR of 5.86% over the forecast period. A flexible endoscope is an optical instrument that transmits light and captures images for observation. These instruments are equipped with flexible transparent fibers. The flexible endoscope segment is anticipated to grow during the forecast period due to its advantages over other alternatives, increasing launches, and higher adoption rates.

The extensive use of endoscopes is necessary for diagnosing various chronic diseases such as inflammatory bowel diseases (IBD), stomach cancer, colon cancer, respiratory infections, respiratory tumors, and more. Consequently, the high prevalence of these diseases leads to a surge in demand for flexible endoscopes. For example, according to the American Cancer Society’s 2023 report, there were an estimated 26,380 new cases of stomach cancer diagnosed in the United States in 2022, with an estimated 26,500 new cases projected for 2023. Therefore, the high incidence and prevalence of such chronic diseases drive the demand for flexible endoscopes. Additionally, the launch of new products and approvals by market players are expected to propel the growth of the flexible endoscope segment. An example of this is Boston Scientific receiving FDA approval for the EXALT Model B Single-Use Bronchoscope in August 2021. This bronchoscope is specifically designed for complex respiratory procedures in the ICU. Consequently, significant growth is expected in the flexible endoscope segment due to the increasing prevalence of diseases, the advantages offered by flexible endoscopes, and continuous product launches.

In terms of applications, the gastroenterology segment held the largest market share in 2022, amounting to USD 7,486 million, and it is expected to witness a CAGR of 5.16% over the forecast period. Gastrointestinal endoscopy involves the use of a long, flexible, lighted instrument called an endoscope to examine the digestive system by inserting it either through the rectum or down through the throat. This procedure is used to evaluate and treat disorders of the esophagus, stomach, small intestine, colon, pancreas, and bile ducts. The growth of the gastroenterology segment is primarily driven by the increasing incidence of gastrointestinal diseases across all age groups. Examples of such disorders include dyspepsia, irritable bowel syndrome, and constipation. Gastroesophageal reflux disease is also a prevalent type of organic gastrointestinal disorder. The growing burden of gastrointestinal diseases, coupled with the aging population, fuels the demand for gastrointestinal endoscopy. Gastrointestinal tumors are the second leading cause of cancer-related deaths globally, and endoscopy has become the standard method for diagnosing gastrointestinal cancers. Consequently, the increasing number of endoscopic procedures for early cancer detection is expected to boost the market in the coming years, particularly for gastrointestinal stromal tumors originating in the rectum, colon, and esophagus.

Geographically, North America dominated the market in 2022, with a market share of USD 12,785 million, and it is projected to grow at a CAGR of 6.45% over the forecast period. The region’s endoscopy market is driven by the high burden of diseases such as cardiovascular diseases, colorectal cancer, stomach cancer, and the increasing adoption of minimally invasive surgeries. Technological innovations, approvals, product launches, and partnerships by market players also contribute to the market’s growth. For instance, according to data from Cedars-Sinai updated in January 2022, coronary artery bypass graft surgery (CABG) is the most common heart surgery in the United States, with over 300 thousand successful procedures performed each year. This high number of bypass surgeries may lead to increased demand for image-guided surgical systems, thereby driving the growth of endoscopy devices in the country.

Furthermore, the market in North America is expected to be boosted by an increase in endoscopic procedures for early diagnosis of gastrointestinal and colorectal cancers. As per the American Cancer Society’s 2023 report, there are expected to be approximately 21.5 thousand diagnosed cases of esophagus cancer, 26.5 thousand cases of stomach cancer, and 153 thousand cases of colorectal cancer in the United States in 2023. The high burden of these cancers will drive the demand for endoscopy devices in the country during the forecast period.

The region also experiences significant growth due to the continuous launches and approvals of endoscopy devices. For example, Zsquare, a developer of single-use endoscopes, received FDA 510K clearance in July 2022 to market its product, the Zsquare ENT-Flex Rhinolaryngoscope, in the United States. Additionally, PENTAX Medical launched the Performance Endoscopic Ultrasound (EUS) system in Canada in November 2022. PENTAX Medical is a leading healthcare industry player in diagnostic and therapeutic endoscopy solutions.

Therefore, factors such as increasing product launches, the adoption of minimally invasive imaging and surgeries for chronic diseases, and technological advancements are expected to drive the growth of the endoscopy market in Canada during the forecast period.

---

Competitive Landscape

---

The market exhibits a moderate level of competition and is populated by several prominent global players. These companies strive to establish clear differentiation in their endoscopic systems based on their specific applications. The key market players include Boston Scientific Corporation, Medtronic PLC, Olympus Corporation, Cook Group Incorporated, and Johnson & Johnson.

Key companies profiled in this report include Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated, Richard Wolf GmbH, Johnson & Johnson, Fujifilm Holdings Corporation, Medtronic PLC, Olympus Corporation, Karl Storz SE & Co. KG, Stryker Corporation.

---

Recent Industry Developments

---

In January 2023, AA Medical announced a strategic partnership with Certified Endoscopy Products, a reputable medical device reprocessing company based in Chicago, with expertise in endoscopic devices. Together, AA Medical and Certified Endoscopy will establish a leading medical device reprocessing company that will cater to the needs of the endoscopy, orthopedic, and other surgical device markets.

In August 2022, Medtronic introduced GI Genius, an innovative artificial intelligence module for endoscopy procedures aimed at addressing colorectal cancer in India. This advanced medical solution provides real-time data and empowers physicians with enhanced visualization during colonoscopy, enabling them to detect and treat colorectal cancer more effectively. The introduction of GI Genius represents a significant step forward in improving outcomes for patients with colorectal cancer through cutting-edge technology and augmented capabilities for physicians.

---

Key Questions Answered

---

What is the duration of the study period for the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market has been studied from 2018 to 2028.

What is the growth rate of the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market is experiencing a compound annual growth rate (CAGR) of 6.56% over the next five years.

What is the size of the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market is projected to reach USD 33,271 million in 2022 and is expected to grow at a CAGR of 6.56% to reach USD 45,420 million by 2028.

Which region exhibits the highest growth rate in the Global Endoscopy Devices Market?
The Asia Pacific region demonstrates the highest CAGR between 2018 and 2028 in the Global Endoscopy Devices Market.

Which region holds the largest share in the Global Endoscopy Devices Market?
In 2022, North America holds the highest market share in the Global Endoscopy Devices Market.

Who are the key players operating in the Global Endoscopy Devices Market?
The major companies operating in the Global Endoscopy Devices Market include Medtronic PLC, Olympus Corporation, Cook Group Incorporated, Johnson & Johnson, and Boston Scientific Corporation.